Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort

Madrid Health Service

Status: Completed

Conditions: Ulcer Hemorrhage; Gastrointestinal Hemorrhage; Tumor Bleeding

Treatments: Device: Hemospray®

Study type: Observational

Funder types: Other

Identifiers

NCT03611504

HRC-HEMOSPRAY

Details and patient eligibility

About

This is an observational, retrospective, analytical, and multicenter study conducted at 17 hospitals. Our research aims to assess the effectiveness of Hemospray® in patients with gastrointestinal bleeding in clinical practice. Besides, we aim to detect predictors of treatment failure defined as unsuccessful immediate hemostasis or rebleeding.

Enrollment: 261 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with gastrointestinal bleeding treated with Hemospray®.

Exclusion criteria

• None.

Trial design

261 participants in 1 patient group

Hemospray® group

Description:

Patients with gastrointestinal bleeding treated with Hemospray®.

Treatment:

Device: Hemospray®